#294 Collaboration, coordination and clinical trials with founder and CEO Zina Sarif
The Healthtech Podcast
00:00
The Heart Path in the Wind
Chris Bock has been working on using CRISPR, cosine technologies and to personalize therapies in the space for years. He decided to leave academia and drug discovery and move to clinical trials. His ambition was if we can reduce shorten the timeline down to seven years, we literally could have the cycle of innovation.
Transcript
Play full episode
